Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ho

Showing results (971-980 of 1,367) with videos related to

Pageof 137
Sort By:
Oncoimmunology|July 29, 2016
Lenalidomide enhances myeloma-specific T-cell responses in vivo and in vitroIsabelle Krämer, Melanie Engelhardt, Sabrina Fichtner, et al.
The New England Journal of Medicine|January 3, 1985
Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III)M S Hirsch, G P Wormser, R T Schooley, et al.
Leukemia & Lymphoma|January 17, 2018
The molecular signature of AML with increased ALDH activity suggests a stem cell originRachel Blume, Eugen Rempel, Linda Manta, et al.
Biochemical Pharmacology|August 17, 2010
IFN-γ activated JAK1 shifts CD40-induced cytokine profiles in human antigen-presenting cells toward high IL-12p70 and low IL-10 productionMichael Conzelmann, Andreas H Wagner, Anke Hildebrandt, et al.
Forensic Science International|June 12, 2010
Human cardiovascular effects of a new generation conducted electrical weaponJeffrey D Ho, Donald M Dawes, Robert F Reardon, et al.
Journal of Virology|July 29, 2004
Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent mannerJ A McKeating, L Q Zhang, C Logvinoff, et al.
Oncotarget|December 16, 2014
Mesenchymal stem cells are resistant to carbon ion radiotherapyNils H Nicolay, Yingying Liang, Ramon Lopez Perez, et al.
Cell|June 18, 2016
Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing ActivityYaoxing Huang, Jian Yu, Anastasia Lanzi, et al.
Journal of Virology|November 1, 1994
Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biologyF Gao, L Yue, D L Robertson, et al.
BMC Cancer|December 14, 2011
A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcomaThomas Schmitt, Burkhard Lehner, Bernd Kasper, et al.
Pageof 137

Showing results (971-980 of 1,367) with videos related to

Sort By:
Pageof 137
Oncoimmunology|July 29, 2016
Lenalidomide enhances myeloma-specific T-cell responses in vivo and in vitroIsabelle Krämer, Melanie Engelhardt, Sabrina Fichtner, et al.
The New England Journal of Medicine|January 3, 1985
Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III)M S Hirsch, G P Wormser, R T Schooley, et al.
Leukemia & Lymphoma|January 17, 2018
The molecular signature of AML with increased ALDH activity suggests a stem cell originRachel Blume, Eugen Rempel, Linda Manta, et al.
Biochemical Pharmacology|August 17, 2010
IFN-γ activated JAK1 shifts CD40-induced cytokine profiles in human antigen-presenting cells toward high IL-12p70 and low IL-10 productionMichael Conzelmann, Andreas H Wagner, Anke Hildebrandt, et al.
Forensic Science International|June 12, 2010
Human cardiovascular effects of a new generation conducted electrical weaponJeffrey D Ho, Donald M Dawes, Robert F Reardon, et al.
Journal of Virology|July 29, 2004
Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent mannerJ A McKeating, L Q Zhang, C Logvinoff, et al.
Oncotarget|December 16, 2014
Mesenchymal stem cells are resistant to carbon ion radiotherapyNils H Nicolay, Yingying Liang, Ramon Lopez Perez, et al.
Cell|June 18, 2016
Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing ActivityYaoxing Huang, Jian Yu, Anastasia Lanzi, et al.
Journal of Virology|November 1, 1994
Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biologyF Gao, L Yue, D L Robertson, et al.
BMC Cancer|December 14, 2011
A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcomaThomas Schmitt, Burkhard Lehner, Bernd Kasper, et al.
Pageof 137